Epana BioListed
epana.biobiotech_life_sciences
Epana Bio focuses on treating autoimmune diseases by targeting their cellular origin, utilizing genomics and AI to develop tailored therapies.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Epana Bio focuses on treating autoimmune diseases by targeting their cellular origin, utilizing genomics and AI to develop tailored therapies.
Noetik is a comprehensive search directory platform that provides resources across multiple industries and topics, focusing on e-commerce and consumer products.
EnPlusOne Bio is a biotechnology company focused on enhancing RNA therapeutics through an innovative enzymatic platform that allows for unrestricted synthesis and manufacturing of…
Cytovale develops an innovative medical device for the rapid diagnosis of sepsis, utilizing their proprietary IntelliSep technology.
Immusoft is the world leader in the development of B cells as biofactories for therapeutic protein delivery, pioneering a novel approach called Immune System Programming (ISP™) to…
Details are not available yet. The company remains listed.
ZymoChem manufactures bio-based products with increased yields, utilizing proprietary Carbon Conserving (C2) microbes to convert renewable feedstocks into high-value materials. Th…
A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Their platforms, AlphaSeq…
Passkey Therapeutics is focused on transforming pharmaceutical R&D by leveraging biological complexity to develop synergistic multifunctional therapeutics (SMThs) that target mult…
Canaery is developing the world’s first nose-computer interface (NCI) that combines the natural sense of smell with advanced neurotechnology and artificial intelligence to interpr…
Twelve is a carbon transformation company that converts captured carbon dioxide into valuable chemicals, fuels, and other essential products typically made from fossil fuels.
Using immune organoids and AI to design drugs that work in people from the start, delivering safe and effective therapies without the need for traditional clinical trials.
Checkerspot harnesses biotechnology to produce high-performance fats and oils through precision fermentation of microalgae, offering sustainable alternatives to conventional sourc…
Incendia Therapeutics is a clinical-stage biotechnology company discovering and developing novel monoclonal antibody therapies that disrupt the tumor microenvironment (TME) to imp…
ShiraTronics is a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic migraine, aiming to improve the quality of life for those…
CellChorus provides high throughput, dynamic analysis of single cells using its TIMING™ platform, which applies visual AI to evaluate cell activation, killing, and movement over t…
Developing novel biologics to target and eliminate key drivers of cancer recurrence and metastasis. Blending early-stage research with innovative platform design to develop next-g…
Ecovative Design specializes in growing sustainable materials using mycelium, transforming agricultural waste into high-fiber protein and various eco-friendly products, including…
Modern Meadow is a pioneering company rooted in synthetic biology and material science, known for creating an animal-free, bio-fabricated leather alternative called INNOVERA™. The…
STRM.BIO is developing a non-viral, cell-derived delivery platform for safe, targeted, and scalable in vivo delivery of genetic medicines, initially focused on rare hematological…
Surf Bio is a preclinical biopharmaceutical company that is transforming how antibodies and biologics are delivered to patients through its Surf SnapShot™ technology, enabling rap…
Details are not available yet. The company remains listed.
Copernic designs novel catalysts for zero-carbon chemicals and e-fuels, focusing on sustainable ammonia production and reducing carbon emissions in the chemical industry.
Phantom Neuro is a future-driven neurotechnology company, spun out of Johns Hopkins University School of Medicine. We are creating the world’s first minimally invasive muscle-mach…